Your browser doesn't support javascript.
loading
Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial.
Rowe, Steven M; Jones, Ieuan; Dransfield, Mark T; Haque, Nazmul; Gleason, Stephen; Hayes, Katy A; Kulmatycki, Kenneth; Yates, Denise P; Danahay, Henry; Gosling, Martin; Rowlands, David J; Grant, Sarah S.
  • Rowe SM; University of Alabama at Birmingham, Department of Medicine, Birmingham, AL, USA.
  • Jones I; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Dransfield MT; University of Alabama at Birmingham, Department of Medicine, Birmingham, AL, USA.
  • Haque N; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Gleason S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Hayes KA; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Kulmatycki K; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Yates DP; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Danahay H; Enterprise Therapeutics, Brighton, UK.
  • Gosling M; Enterprise Therapeutics, Brighton, UK.
  • Rowlands DJ; Sussex Drug Discovery Centre, University of Sussex, Brighton, UK.
  • Grant SS; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Int J Chron Obstruct Pulmon Dis ; 15: 2399-2409, 2020.
Article en En | MEDLINE | ID: mdl-33116455
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinolonas / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinolonas / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article